| Trade Names | |
| Synonyms | |
| Status | |
| Molecule Category | Free-form |
| ATC | A16AX04 |
| UNII | K5BN214699 |
| EPA CompTox | DTXSID9042673 |
| InChI Key | OUBCNLGXQFSTLU-UHFFFAOYSA-N |
|---|---|
| Smiles | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C14H10F3NO5 |
| Molecular Weight | 329.23 |
| AlogP | 2.73 |
| Hydrogen Bond Acceptor | 5.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 94.35 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 23.0 |
| Mechanism of Action | Action | Reference |
|---|---|---|
| 4-hydroxyphenylpyruvate dioxygenase inhibitor | INHIBITOR | FDA |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | 40-40 | - | 37 | 50 |
|
Protein: 4-hydroxyphenylpyruvate dioxygenase Description: 4-hydroxyphenylpyruvate dioxygenase Organism : Homo sapiens P32754 ENSG00000158104 |
||||
| Resources | Reference |
|---|---|
| ChEBI | 50378 |
| ChEMBL | CHEMBL1337 |
| DrugBank | DB00348 |
| DrugCentral | 1944 |
| FDA SRS | K5BN214699 |
| Human Metabolome Database | HMDB0014492 |
| Guide to Pharmacology | 6834 |
| KEGG | D05177 |
| PharmGKB | PA164777037 |
| PubChem | 115355 |
| SureChEMBL | SCHEMBL338795 |
| ZINC | ZINC000100014475 |